EDGAR Filing Documents for 0000921895-16-005107

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0000921895-16-005107

Filing Date

2016-07-07

Accepted

2016-07-07 16:24:20

Documents

Period of Report

2016-07-05

Document Format Files

Seq	Description	Document	Type	Size
1	OWNERSHIP DOCUMENT	form410109002_07072016.html	4
1	OWNERSHIP DOCUMENT	form410109002_07072016.xml	4	6104
	Complete submission text file	0000921895-16-005107.txt		7727

Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016

Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875

Actinium Pharmaceuticals, Inc. (Issuer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1275 YORK AVE. NEW YORK NY 10065

Business Address 1275 YORK AVE. NEW YORK NY 10065 212-639-2000

Memorial Sloan-Kettering Cancer Center (Reporting) CIK: 0001566787 (see all company filings)

State of Incorp.: NY
Type: 4 | Act: 34 | File No.: 001-36374 | Film No.: 161756834